Psomagen, Inc. Logo

Psomagen, Inc.

A contract lab providing multiomics and data analysis solutions for researchers.

950200 | KO

Overview

Corporate Details

ISIN(s):
KR8840150005
LEI:
Country:
United States of America
Address:
City of Wilmington, County of New Castle, State of Delaware, Corporation Trust Cen, Wilmington

Description

Psomagen, Inc. is a contract laboratory service provider specializing in multiomics and data analysis solutions for scientists and clinicians. Operating from CLIA-certified and CAP-accredited facilities, the company offers a comprehensive suite of services to the academic, clinical, and life sciences research communities. Its core offerings encompass genomics, epigenomics, proteomics, transcriptomics, and metagenomics. Psomagen utilizes a range of sequencing technologies, including Sanger sequencing, Next-Generation Sequencing (NGS), and third-generation sequencing. The company also provides specialized solutions such as spatial biology analysis, cell line authentication via STR profiling, and advanced bioinformatics support to analyze complex biological data.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-13 00:00
단일판매ㆍ공급계약체결
Korean 10.2 KB
2025-06-13 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.7 MB
2025-03-31 00:00
정기주주총회결과
Korean 25.7 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.6 KB
2025-03-21 00:00
감사보고서제출
Korean 28.6 KB
2025-03-21 00:00
사업보고서 (2024.12)
Korean 2.2 MB
2025-03-21 00:00
[기재정정]주주총회소집공고
Korean 346.5 KB
2025-03-14 00:00
주주총회소집결의
Korean 14.2 KB
2025-03-14 00:00
주주총회소집공고
Korean 209.4 KB
2025-02-14 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.8 KB
2025-01-17 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 15.7 KB
2025-01-03 00:00
주식등의대량보유상황보고서(일반)
Korean 105.3 KB
2025-01-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB

Automate Your Workflow. Get a real-time feed of all Psomagen, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Psomagen, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Psomagen, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.